Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics
暂无分享,去创建一个
Esther G C Troost | Philippe Lambin | Henry C Woodruff | Wouter van Elmpt | Ursula Nestle | Cary Oberije | Arthur Jochems | Tanja Schimek-Jasch | Fabrice Denis | J. E. van Timmeren | P. Lambin | R. Leijenaar | S. Carvalho | A. Jochems | H. Woodruff | W. V. van Elmpt | D. de Ruysscher | C. Oberije | U. Nestle | E. Troost | J. Muratet | F. Denis | T. Schimek-Jasch | Ralph T H Leijenaar | Dirk de Ruysscher | Jean-Pierre Muratet | Sara Carvalho | Janna E van Timmeren | W. van Elmpt
[1] V. Valentini,et al. 18 F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose , 2012, Radiation Oncology.
[2] I. Apostolova,et al. Comparative evaluation of SUV, tumor-to-blood standard uptake ratio (SUR), and dual time point measurements for assessment of the metabolic uptake rate in FDG PET , 2016, EJNMMI Research.
[3] Thomas Carlier,et al. Revisiting the Robustness of PET-Based Textural Features in the Context of Multi-Centric Trials , 2016, PloS one.
[4] W. Niessen,et al. Quantification of Heterogeneity as a Biomarker in Tumor Imaging: A Systematic Review , 2014, PloS one.
[5] Peter Smeets,et al. Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[6] W. Oyen,et al. 18F-FDG PET Early Response Evaluation of Locally Advanced Non–Small Cell Lung Cancer Treated with Concomitant Chemoradiotherapy , 2013, The Journal of Nuclear Medicine.
[7] R. Rami-Porta,et al. Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual data , 2015, European Respiratory Journal.
[8] Steffen Löck,et al. Image biomarker standardisation initiative - feature definitions , 2016, ArXiv.
[9] Karel G M Moons,et al. A new framework to enhance the interpretation of external validation studies of clinical prediction models. , 2015, Journal of clinical epidemiology.
[10] Dimitrios I. Fotiadis,et al. Machine learning applications in cancer prognosis and prediction , 2014, Computational and structural biotechnology journal.
[11] J. E. van Timmeren,et al. Influence of gray level discretization on radiomic feature stability for different CT scanners, tube currents and slice thicknesses: a comprehensive phantom study , 2017, Acta oncologica.
[12] Ronald Boellaard,et al. Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [18F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation , 2016, Molecular Imaging and Biology.
[13] Timothy Solberg,et al. Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers , 2018, Medical physics.
[14] P. Marsden,et al. False Discovery Rates in PET and CT Studies with Texture Features: A Systematic Review , 2015, PloS one.
[15] F. Harrell,et al. Evaluating the yield of medical tests. , 1982, JAMA.
[16] Fabrice Denis,et al. Early Assessment of Metabolic Response by 18F-FDG PET During Concomitant Radiochemotherapy of Non–Small Cell Lung Carcinoma Is Associated With Survival: A Retrospective Single-Center Study , 2015, Clinical nuclear medicine.
[17] Andre Dekker,et al. Prospective validation of pathologic complete response models in rectal cancer: Transferability and reproducibility , 2017, Medical physics.
[18] Osama Mawlawi,et al. Stage III Non-Small Cell Lung Cancer: Prognostic Value of FDG PET Quantitative Imaging Features Combined with Clinical Prognostic Factors. , 2016, Radiology.
[19] P. Lambin,et al. Predicting outcomes in radiation oncology—multifactorial decision support systems , 2013, Nature Reviews Clinical Oncology.
[20] Baosheng Li,et al. Standard uptake value and metabolic tumor volume of 18F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[21] Laurence Court,et al. Harmonizing the pixel size in retrospective computed tomography radiomics studies , 2017, PloS one.
[22] Peter Balter,et al. Delta-radiomics features for the prediction of patient outcomes in non–small cell lung cancer , 2017, Scientific Reports.
[23] R. Timmerman,et al. Role of interim 18F-FDG-PET/CT for the early prediction of clinical outcomes of Non-Small Cell Lung Cancer (NSCLC) during radiotherapy or chemo-radiotherapy. A systematic review , 2017, European Journal of Nuclear Medicine and Molecular Imaging.
[24] Laurence Court,et al. Effect of tube current on computed tomography radiomic features , 2018, Scientific Reports.
[25] Paul Kinahan,et al. Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy. , 2010, Seminars in ultrasound, CT, and MR.
[26] P. Lambin,et al. Quality assessment of positron emission tomography scans: recommendations for future multicentre trials , 2017, Acta oncologica.
[27] Fei Yang,et al. Quantitative radiomics: impact of stochastic effects on textural feature analysis implies the need for standards , 2015, Journal of medical imaging.
[28] Patrick Granton,et al. Radiomics: extracting more information from medical images using advanced feature analysis. , 2012, European journal of cancer.
[29] Carsten Brink,et al. Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT images. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[30] D. Townsend,et al. Impact of Image Reconstruction Settings on Texture Features in 18F-FDG PET , 2015, The Journal of Nuclear Medicine.
[31] M. Soussan,et al. A Postreconstruction Harmonization Method for Multicenter Radiomic Studies in PET , 2018, The Journal of Nuclear Medicine.
[32] L Cozzi,et al. PET Radiomics in NSCLC: state of the art and a proposal for harmonization of methodology , 2017, Scientific Reports.
[33] Johannes H A M Kaanders,et al. Comparison of Tumor Volumes Derived from Glucose Metabolic Rate Maps and SUV Maps in Dynamic 18F-FDG PET , 2008, Journal of Nuclear Medicine.
[34] G. Russo,et al. Predictive and Prognostic Value of Early Disease Progression by PET Evaluation in Advanced Non-Small Cell Lung Cancer , 2016, Oncology.
[35] W. Oyen,et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[36] Philippe Lambin,et al. Response Assessment Using 18F-FDG PET Early in the Course of Radiotherapy Correlates with Survival in Advanced-Stage Non–Small Cell Lung Cancer , 2012, The Journal of Nuclear Medicine.
[37] P. Royston,et al. External validation of a Cox prognostic model: principles and methods , 2013, BMC Medical Research Methodology.
[38] Andre Dekker,et al. Radiomics: the process and the challenges. , 2012, Magnetic resonance imaging.
[39] Robert J. Gillies,et al. The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis , 2015, Scientific Reports.
[40] R. Jeraj,et al. Variability of textural features in FDG PET images due to different acquisition modes and reconstruction parameters , 2010, Acta oncologica.
[41] P. Lambin,et al. Robust Radiomics Feature Quantification Using Semiautomatic Volumetric Segmentation , 2014, PloS one.
[42] Eric J. W. Visser,et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[43] Jinzhong Yang,et al. Measuring Computed Tomography Scanner Variability of Radiomics Features , 2015, Investigative radiology.
[44] P. Lambin,et al. Decision support systems for personalized and participative radiation oncology☆ , 2017, Advanced drug delivery reviews.
[45] Eric R. Ziegel,et al. The Elements of Statistical Learning , 2003, Technometrics.
[46] P. Lambin,et al. Radiomics: the bridge between medical imaging and personalized medicine , 2017, Nature Reviews Clinical Oncology.
[47] R. Tibshirani. Regression Shrinkage and Selection via the Lasso , 1996 .
[48] Steffen Löck,et al. Why validation of prognostic models matters? , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.